These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 20879856

  • 1. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.
    Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA.
    Clin Infect Dis; 2010 Nov 01; 51(9):1074-80. PubMed ID: 20879856
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ, Nix DE, Armstrong EP.
    Ann Pharmacother; 2004 Sep 01; 38(9):1377-82. PubMed ID: 15266044
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction.
    Wong JR, Bauer KA, Mangino JE, Goff DA.
    Ann Pharmacother; 2012 Nov 01; 46(11):1484-90. PubMed ID: 23136356
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
    Schreiber MP, Chan CM, Shorr AF.
    J Crit Care; 2011 Aug 01; 26(4):395-401. PubMed ID: 21036521
    [Abstract] [Full Text] [Related]

  • 7. [Interest of real-time PCR Xpert MRSA/SA on GeneXpert(®) DX System in the investigation of staphylococcal bacteremia].
    Scanvic A, Courdavault L, Sollet JP, Le Turdu F.
    Pathol Biol (Paris); 2011 Apr 01; 59(2):67-72. PubMed ID: 20832193
    [Abstract] [Full Text] [Related]

  • 8. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
    Lodise TP, McKinnon PS.
    Diagn Microbiol Infect Dis; 2005 Jun 01; 52(2):113-22. PubMed ID: 15964499
    [Abstract] [Full Text] [Related]

  • 9. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 10. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML.
    Clin Infect Dis; 2004 Feb 01; 38(3):448-51. PubMed ID: 14727222
    [Abstract] [Full Text] [Related]

  • 11. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting.
    Spencer DH, Sellenriek P, Burnham CA.
    Am J Clin Pathol; 2011 Nov 01; 136(5):690-4. PubMed ID: 22031306
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures.
    Stamper PD, Cai M, Howard T, Speser S, Carroll KC.
    J Clin Microbiol; 2007 Jul 01; 45(7):2191-6. PubMed ID: 17522275
    [Abstract] [Full Text] [Related]

  • 14. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia.
    Murray RJ, Lim TT, Pearson JC, Grubb WB, Lum GD.
    Int J Infect Dis; 2004 Sep 01; 8(5):275-83. PubMed ID: 15325596
    [Abstract] [Full Text] [Related]

  • 15. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK.
    Clin Microbiol Infect; 2008 Mar 01; 14 Suppl 2():26-34. PubMed ID: 18226087
    [Abstract] [Full Text] [Related]

  • 16. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR.
    Clin Infect Dis; 2009 May 15; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [Abstract] [Full Text] [Related]

  • 17. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E, Broex E, Ament A, Deurenberg RH, Smeets E, Scheres J, van Tiel FH, Gordts B, Stobberingh EE.
    J Hosp Infect; 2008 Apr 15; 68(4):301-7. PubMed ID: 18353496
    [Abstract] [Full Text] [Related]

  • 18. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.
    Clin Infect Dis; 2008 Mar 15; 46(6):799-806. PubMed ID: 18266610
    [Abstract] [Full Text] [Related]

  • 19. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.
    Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, Avalos-Mishaan A, Mason EO, Kaplan SL.
    Pediatrics; 2005 Mar 15; 115(3):642-8. PubMed ID: 15741366
    [Abstract] [Full Text] [Related]

  • 20. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M, Eykyn SJ, Gransden WR, Chinn S.
    Clin Infect Dis; 2003 Dec 01; 37(11):1453-60. PubMed ID: 14614667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.